Seven abstracts represent data across migraine, childhood-onset epilepsy and multiple system atrophy (MSA), highlighting Lundbeck's biology-driven approach to developing treatments for serious brain ...
President and CEO Rick Pauls outlined the company’s development programs for its lead candidate, DM199, during a presentation ...
A 67-year-old man with a history of type 2 diabetes, diabetic peripheral neuropathy, and hypertension presents to the emergency department with a skin ulceration on the bottom of his great toe ...
Use of an unapproved triple-hormone receptor agonist bought online led to extreme side effects stemming from intractable ...
CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology, inflammation, and other key ...
El Salvador's President Nayib Bukele announced on Tuesday in a national broadcast the launch of the second phase of Dr. SV, a ...
Unicycive Therapeutics, Inc. (UNCY) 25th Annual Needham Virtual Healthcare Conference April 15, 2026 3:45 PM EDTCompany ParticipantsShalabh Gupta - ...
Safety featured universal TEAEs and 92% grade ≥3 events; anemia (39.5%) predominated, discontinuations were frequent, and ...
Haitian American midwife and filmmaker Stéphanie Etienne’s first documentary “Listen to Me,” which examines the Black ...
Introduction In aortic valve disease, several interventions are available. In young people who are still growing, or ...
Global hypertension prevalence rose between 2000 and 2020, with significant increases in low- and middle-income countries and rising global disparities.
Hypertension prevalence among US adults is rising and apparent treatment-resistant hypertension rates remain high.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results